AMERISAFE (NASDAQ:AMSF – Get Free Report) had its target price decreased by stock analysts at Citizens Jmp from $50.00 to $45.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has a “market outperform” rating on the insurance provider’s stock. Citizens Jmp’s price target would suggest a potential upside of 35.95% from the company’s current price.
A number of other equities analysts also recently weighed in on the stock. Citigroup reaffirmed a “market outperform” rating on shares of AMERISAFE in a research note on Friday, January 16th. Morgan Stanley set a $55.00 price target on shares of AMERISAFE in a report on Friday, January 16th. Weiss Ratings lowered shares of AMERISAFE from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, March 2nd. Truist Financial lowered their price target on shares of AMERISAFE from $45.00 to $36.00 and set a “hold” rating for the company in a report on Friday, February 27th. Finally, Wall Street Zen lowered shares of AMERISAFE from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, AMERISAFE has a consensus rating of “Hold” and a consensus target price of $45.33.
Get Our Latest Stock Report on AMSF
AMERISAFE Stock Performance
AMERISAFE (NASDAQ:AMSF – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The insurance provider reported $0.51 earnings per share for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.06). The company had revenue of $81.59 million for the quarter, compared to analysts’ expectations of $80.05 million. AMERISAFE had a return on equity of 15.89% and a net margin of 14.86%. Equities analysts expect that AMERISAFE will post 2.45 EPS for the current fiscal year.
Institutional Trading of AMERISAFE
Institutional investors have recently added to or reduced their stakes in the business. Clearstead Advisors LLC lifted its stake in AMERISAFE by 142.4% in the fourth quarter. Clearstead Advisors LLC now owns 657 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 386 shares during the last quarter. Hantz Financial Services Inc. lifted its stake in AMERISAFE by 159.6% in the fourth quarter. Hantz Financial Services Inc. now owns 714 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 439 shares during the last quarter. Quarry LP lifted its stake in AMERISAFE by 346.9% in the third quarter. Quarry LP now owns 943 shares of the insurance provider’s stock valued at $41,000 after acquiring an additional 732 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new stake in AMERISAFE in the fourth quarter valued at approximately $54,000. Finally, GAMMA Investing LLC lifted its stake in AMERISAFE by 38.6% in the third quarter. GAMMA Investing LLC now owns 1,633 shares of the insurance provider’s stock valued at $72,000 after acquiring an additional 455 shares during the last quarter. 97.41% of the stock is currently owned by institutional investors and hedge funds.
About AMERISAFE
Amerisafe, Inc (NASDAQ: AMSF) is a specialty provider of workers’ compensation insurance products and services in the United States. The company focuses on underwriting and managing workers’ compensation policies for small to mid-sized public and private businesses, particularly in higher-hazard industries such as retail, manufacturing, distribution and wholesale. Through its network of independent agents, Amerisafe delivers tailored coverage solutions that combine robust risk management support with loss prevention programs designed to enhance workplace safety.
In addition to core insurance offerings, Amerisafe provides extensive risk control resources, including safety training, on-site consultations and claims management services.
Read More
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.
